Journal of Anesthesia

, Volume 25, Issue 6, pp 864–871

Impact of remifentanil introduction on practice patterns in general anesthesia

  • Kanji Uchida
  • Hideo Yasunaga
  • Hiroaki Miyata
  • Masahiko Sumitani
  • Hiromasa Horiguchi
  • Ken Kuwajima
  • Shinya Matsuda
  • Yoshitsugu Yamada
Original Article

Abstract

Purpose

The introduction of new medicine can change clinical practice patterns and may affect patient outcomes. In the present study, we investigated whether introduction of remifentanil in Japan affected the practice patterns of anesthesia.

Methods

Using the Japanese Diagnosis Procedure Combination database, we extracted records of 423,491 patients who underwent surgery with general anesthesia in 243 hospitals before (2006) and after (2007) the introduction of remifentanil, and identified anesthetic agents used for each patient. A hierarchical mixed-effects logistic regression analysis was performed to analyze the factors that affected selection of remifentanil. Further, we compared postoperative length of stay (LOS), in-hospital mortality, and total costs between 2006 and 2007.

Results

In 2007, remifentanil was used for up to 41.4% of all general anesthesia, accompanied by a reduction in nitrous oxide use and an increase in total intravenous anesthesia. Female gender, increasing age, and preoperative comorbidities including diabetes mellitus, hypertension, liver cirrhosis, and chronic renal failure were positively associated with the use of remifentanil, whereas accompanying cardiac disease and co-application of epidural anesthesia were negatively associated. In 2007, a similar in-hospital death rate, similar or decreased total costs, slightly reduced duration of anesthesia, and substantially reduced postoperative LOS were seen compared to those in 2006.

Conclusions

Our data revealed rapid changes in practice patterns in anesthesia after the introduction of remifentanil in Japan. Remifentanil was used more often in patients with comorbidities and without epidural anesthesia, and its introduction did not affect increase in total medical costs.

Keywords

Remifentanil Anesthetic practice Postoperative outcome In-patient medical cost 

Supplementary material

540_2011_1221_MOESM1_ESM.doc (48 kb)
Supplemental Table 1 (DOC 48 kb)
540_2011_1221_MOESM2_ESM.doc (44 kb)
Supplemental Table 2 (DOC 44 kb)

References

  1. 1.
    Horiguchi H, Yasunaga H, Hashimoto H, Matsuda S. Impact of drug-eluting stents on treatment option mix for coronary artery disease in Japan. Circ J. 2010;74:1635–43.PubMedCrossRefGoogle Scholar
  2. 2.
    van Vollenhoven RF. Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol. 2009;5:531–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Ligthart S, Vlemmix F, Dendukuri N, Brophy JM. The cost-effectiveness of drug-eluting stents: a systematic review. CMAJ. 2007;176:199–205.PubMedCrossRefGoogle Scholar
  4. 4.
    Clergue F, Auroy Y, Péquignot F, Jougla E, Lienhart A, Laxenaire MC. French survey of anesthesia in 1996. Anesthesiology. 1999;91:1509–20.PubMedCrossRefGoogle Scholar
  5. 5.
    Cohen MM, Rose DK, Yee DA. Changing anesthesiologists’ practice patterns. Can it be done? Anesthesiology. 1996;85:260–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet. 1995;29:80–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83:968–75.PubMedCrossRefGoogle Scholar
  8. 8.
    Komatsu R, Turan AM, Orhan-Sungur M, McGuire J, Radke OC, Apfel CC. Remifentanil for general anaesthesia: a systematic review. Anaesthesia. 2007;62:1266–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Matsuda S, Ishikawa KB, Kuwabara K, Fujimori K, Fushimi K, Hashimoto H. Development and use of the Japanese case-mix system. Eurohealth. 2008;14:25–30.Google Scholar
  10. 10.
    Sumitani M, Uchida K, Yasunaga H, Horiguchi H, Kusakabe Y, Matsuda S, Yamada Y. Prevalence of malignant hyperthermia and relationship with anesthetics in Japan. Data from the diagnosis procedure combination database. Anesthesiology. 2011;114:84–90.PubMedCrossRefGoogle Scholar
  11. 11.
    Kuwabara K, Matsuda S, Imanaka Y, Fushimi K, Hashimoto H, Ishikawa KB, Horiguchi H, Hayashida K, Fujimori K, Ikeda S, Yasunaga H. Injury severity score, resource use, and outcome for trauma patients within a Japanese administrative database. J Trauma. 2010;68:463–70.PubMedCrossRefGoogle Scholar
  12. 12.
    Yasunaga H, Yanaihara H, Fuji K, Horiguchi H, Hashimoto H, Matsuda S. Impact of hospital volume on postoperative complications and in-hospital mortality following renal surgery: data from the Japanese Diagnosis Procedure Combination Database. Urology. 2010;76:548–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Matsui H, Hashimoto H, Horiguchi H, Yasunaga H, Matsuda S. An exploration of the association between very early rehabilitation and outcome for the patients with acute ischaemic stroke in Japan: a nationwide retrospective cohort survey. BMC Health Serv Res. 2010;10:213.PubMedCrossRefGoogle Scholar
  14. 14.
    Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the Nationwide Inpatient Sample. Chest. 2009;136:983–90.PubMedCrossRefGoogle Scholar
  15. 15.
    Morita K, Kawashima Y, Irita K, Iwao Y, Seo N, Tsuzaki K. Perioperative mortality and morbidity in the year 2000 in 520 certified training hospitals of Japanese Society of Anesthesiologists with a special reference to age: report of Japanese Society of Anesthesiologists Committee on Operating Room Safety. Masui (Jpn J Anesthesiol). 2002;51:1285–1296 (in Japanese with English abstract).Google Scholar
  16. 16.
    Iwao Y, Kawashima Y, Seo N, Kobayashi T, Goto Y, Morita K, Irita K, Tsuzaki K, Dohi S, Tanaka Y, Shiraishi Y, Tozaki Y, Nakao Y, Japan Society of Anesthesiologist Committee on Operating Room Safety. Perioperative mortality and morbidity for the year 2000 in 532 Japanese Society of Anesthesiologists certified training hospitals with a special reference to surgical sites: report of the Japan Society of Anesthesiologists Committee on Operating Room Safety. Masui (Jpn J Anesthesiol). 2002;51:791–800 (in Japanese with English abstract).Google Scholar
  17. 17.
    McGavock H, Webb CH, Johnston GD, Milligan E. Market penetration of new drugs in one United Kingdom region: implications for general practitioners and administrators. Br Med J. 1993;307:1118–20.CrossRefGoogle Scholar
  18. 18.
    Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA Jr, Wu CL. Efficacy of postoperative epidural analgesia: a meta-analysis. JAMA. 2003;290:2455–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia. Their role in postoperative outcome. Anesthesiology. 1995;82:1474–506.PubMedCrossRefGoogle Scholar
  20. 20.
    Elliott P, O’Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK. Severe cardiovascular depression with remifentanil. Anesth Analg. 2000;91:58–61.PubMedGoogle Scholar
  21. 21.
    Pedersen T. Evidence-based anaesthesia and health economics. Best Pract Res Clin Anaesthesiol. 2006;20:347–60.PubMedCrossRefGoogle Scholar
  22. 22.
    Scott LJ, Perry CM. Spotlight on remifentanil for general anaesthesia. CNS Drugs. 2005;19:1069–74.PubMedCrossRefGoogle Scholar
  23. 23.
    Nomura H, Nakayama T. The Japanese healthcare system: the issue is to solve the “tragedy of the commons” without making another. Br Med J. 2005;331:648–9.CrossRefGoogle Scholar
  24. 24.
    Stachnik J. Inhaled anesthetic agents. Am J Health Syst Pharm. 2006;63:623–34.PubMedCrossRefGoogle Scholar
  25. 25.
    Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N, IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–51.PubMedCrossRefGoogle Scholar
  26. 26.
    De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg. 2005;100:1584–93.PubMedCrossRefGoogle Scholar
  27. 27.
    von Dossow V, Luetz A, Haas A, Sawitzki B, Wernecke KD, Volk HD, Spies CD. Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery. J Int Med Res. 2008;36:1235–47.Google Scholar
  28. 28.
    Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, Nygren J, Hausel J, Soop M, Andersen J, Kehlet H. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24:466–7.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2011

Authors and Affiliations

  • Kanji Uchida
    • 1
  • Hideo Yasunaga
    • 2
  • Hiroaki Miyata
    • 3
  • Masahiko Sumitani
    • 1
  • Hiromasa Horiguchi
    • 2
  • Ken Kuwajima
    • 1
  • Shinya Matsuda
    • 4
  • Yoshitsugu Yamada
    • 1
  1. 1.Department of AnesthesiologyTokyo University Graduate School of MedicineTokyoJapan
  2. 2.Department of Health Management and PolicyTokyo University Graduate School of MedicineTokyoJapan
  3. 3.Department of Health Quality AssessmentTokyo University Graduate School of MedicineTokyoJapan
  4. 4.Department of Preventive Medicine and Community HealthUniversity of Occupational and Environmental HealthKitakyushuJapan

Personalised recommendations